Live Nation at Goldman Sachs conference: global growth still early

Live Nation said it has sold more than 155 million tickets year-to-date, up 12% year over year, and remains on track for 175 million fans in 2024, with a longer-term target of 225 million. Management reiterated a multi-year goal to compound adjusted operating income at a double-digit rate, citing international expansion, Venue Nation returns above 20% on incremental capital, and mid-teens Ticketmaster AOI growth in Q2. Demand indicators remain resilient, with stable sell-through and cancellation rates and ticket pricing up about 20% since 2019 versus roughly 30% inflation, though DOJ settlement review and state antitrust remedies proceedings remain a material overhang.

Analysis

The incremental equity question is not demand durability but whether LYV can convert international venue buildout into earnings without taking on a higher regulatory discount. Venue ownership improves local promotion, ticketing and sponsorship capture simultaneously, creating a flywheel that smaller promoters and ticketing rivals cannot readily replicate; the offset is that this vertical integration is precisely what raises remedy risk. At ~27.6x EBITDA, the stock requires sustained double-digit AOI compounding, leaving limited tolerance for a remedy that constrains exclusive venue arrangements, ticketing bundling, or acquisition activity.

Near term (days to 3 months), the DOJ-settlement review is the dominant valuation catalyst rather than conference commentary. A settlement accepted substantially as proposed could remove a material overhang and support multiple expansion; adverse modifications or a more aggressive state remedy framework would shift the debate from growth to structural margin impairment. Management's demand observations are useful but not independently sufficient: the relevant falsification is a deterioration in sell-through, onsite per-cap growth, or forward concert gross trends as higher oil and bond yields pressure discretionary budgets.

The non-obvious beneficiary of reduced LYV conduct flexibility is STUB: tighter primary-market restrictions, weaker transfer controls, or mandated interoperability could increase secondary inventory and consumer traffic, even if artists prefer a more controlled primary ecosystem. Conversely, LYV's continued investment in international venues could narrow third-party ticketing availability over 6-18 months, making international execution—especially new-market launch economics—the key competitive variable rather than domestic ticket-price growth.

Contrarian view: consensus may be over-crediting the long runway while underpricing the capital intensity and local execution risk embedded in venue expansion. Returns on incremental capital can look attractive before full-cycle FX, construction-cost, utilization, and regulatory costs; a higher-rate environment makes the claimed financing advantage more important to verify through venue-level cash flow, not corporate leverage optics.

Key Decisions for Investors

• Maintain LYV as a watch-to-buy, not an immediate full-size long: initiate only after the DOJ review outcome is public and remedies preserve venue/ticketing commercial flexibility. Target a 6-12 month rerating on overhang removal; exit or hedge if the order mandates meaningful separation, exclusivity limits, or interoperability that threatens Ticketmaster take rate.
• For event-driven exposure, use a defined-risk LYV call spread dated beyond the expected regulatory decision window rather than outright calls. This captures a favorable settlement catalyst while limiting loss if the stock remains range-bound on its already demanding EBITDA multiple.
• Consider a 6-12 month long STUB / short LYV relative-value position if remedies broaden secondary-market access or restrict primary-platform controls. Cover the pair if the settlement is accepted with modest behavioral terms, as LYV's integrated venue flywheel would likely reassert itself.
• Monitor quarterly indicators before adding: international operating-fan growth, venue-level return disclosures, Ticketmaster AOI versus fee-bearing ticket growth, and sell-through/cancellations. A sustained miss in any two metrics, or evidence that higher energy and rates are reducing per-fan spend, invalidates the premium-growth case.